132 related articles for article (PubMed ID: 12891629)
1. Polymorphisms of estrogen receptor alpha in prostate cancer.
Tanaka Y; Sasaki M; Kaneuchi M; Shiina H; Igawa M; Dahiya R
Mol Carcinog; 2003 Aug; 37(4):202-8. PubMed ID: 12891629
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
4. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
Modugno F; Weissfeld JL; Trump DL; Zmuda JM; Shea P; Cauley JA; Ferrell RE
Clin Cancer Res; 2001 Oct; 7(10):3092-6. PubMed ID: 11595700
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.
Fukatsu T; Hirokawa Y; Araki T; Hioki T; Murata T; Suzuki H; Ichikawa T; Tsukino H; Qiu D; Katoh T; Sugimura Y; Yatani R; Shiraishi T; Watanabe M
Anticancer Res; 2004; 24(4):2431-7. PubMed ID: 15330195
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.
Akisik E; Dalay N
Exp Mol Pathol; 2004 Jun; 76(3):260-3. PubMed ID: 15126109
[TBL] [Abstract][Full Text] [Related]
7. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma.
Baştürk B; Yavaşçaoğlu I; Vuruşkan H; Göral G; Oktay B; Oral HB
Cytokine; 2005 Apr; 30(1):41-5. PubMed ID: 15784411
[TBL] [Abstract][Full Text] [Related]
8. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
Li Z; Habuchi T; Mitsumori K; Kamoto T; Kinoshitu H; Segawa T; Ogawa O; Kato T
J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
[TBL] [Abstract][Full Text] [Related]
9. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
Shen Y; Li DK; Wu J; Zhang Z; Gao E
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
[TBL] [Abstract][Full Text] [Related]
10. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.
Huang SP; Wu WJ; Chang WS; Wu MT; Chen YY; Chen YJ; Yu CC; Wu TT; Lee YH; Huang JK; Huang CH
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2217-24. PubMed ID: 15598783
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of estrogen receptor alpha gene in endometrial cancer.
Sasaki M; Tanaka Y; Kaneuchi M; Sakuragi N; Dahiya R
Biochem Biophys Res Commun; 2002 Sep; 297(3):558-64. PubMed ID: 12270131
[TBL] [Abstract][Full Text] [Related]
12. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
13. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
14. Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients.
Jin SY; Park HH; Li GZ; Lee HJ; Hong MS; Park HJ; Park HK; Seo JC; Yim SV; Chung JH; Lee MH
J Dermatol Sci; 2004 Sep; 35(3):181-6. PubMed ID: 15381239
[TBL] [Abstract][Full Text] [Related]
15. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
[TBL] [Abstract][Full Text] [Related]
16. Association of XPD polymorphisms with prostate cancer in Taiwanese patients.
Bau DT; Wu HC; Chiu CF; Lin CC; Hsu CM; Wang CL; Wang RF; Tsai FJ
Anticancer Res; 2007; 27(4C):2893-6. PubMed ID: 17695467
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort.
Kesarwani P; Mandhani A; Mittal RD
J Urol; 2009 Dec; 182(6):2938-43. PubMed ID: 19846139
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma.
Hsieh YY; Wang YK; Chang CC; Lin CS
Mol Hum Reprod; 2007 Feb; 13(2):117-22. PubMed ID: 17121748
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines.
Bergner CC; Krause FS; Zugor V; Rith T; Schrott KM; Endele S; Engehausen DG
Anticancer Res; 2007; 27(4A):2071-4. PubMed ID: 17649823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
